The chemical class termed C2orf73 Activators encompasses a range of compounds that have the potential to interact with and modulate the activity of the protein encoded by the C2orf73 gene. This class is not characterized by a uniform chemical structure or a singular mechanism of action but rather by the shared ability of these molecules to engage with cellular signaling pathways in which C2orf73 is likely involved. The diversity of this class is exemplified by compounds such as Forskolin, Phorbol 12-myristate 13-acetate (PMA), Ionomycin, and Epidermal Growth Factor (EGF), each with its unique biochemical profile and mode of action. Forskolin, for instance, is known to elevate intracellular cAMP levels, playing a pivotal role in numerous signaling cascades. This action suggests its potential to modulate pathways related to the function of C2orf73. Similarly, PMA activates Protein Kinase C, implicating it in signaling mechanisms that could intersect with the activities of C2orf73.
Further, Ionomycin, acting as a calcium ionophore, alters calcium ion concentrations within cells, a critical factor in many signaling pathways, possibly including those associated with C2orf73. EGF, interacting with its specific receptor, initiates a cascade of signaling events, providing another pathway through which C2orf73 activity may be influenced. This class also includes diverse compounds like Insulin and 1,25-Dihydroxyvitamin D3, each operating through different signaling mechanisms - insulin via receptor tyrosine kinase pathways and vitamin D3 through genomic and non-genomic routes. These compounds represent a broad spectrum of biochemical activity, each potentially contributing to the modulation of C2orf73. Their diverse modes of action illustrate the ability of this class to interact with a variety of cellular processes and signaling pathways. The C2orf73 Activators are thus characterized by their potential functional impact on C2orf73, highlighting the breadth of chemical interactions that can influence protein activity within cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Could activate Protein Kinase C, possibly affecting signaling related to C2orf7 | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Might elevate intracellular calcium, potentially impacting calcium-dependent processes involving C2orf7 | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Might activate insulin signaling pathways that could intersect with the function of C2orf7 | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $325.00 $632.00 $1428.00 $2450.00 $400.00 | 32 | |
May modulate genomic and non-genomic pathways, potentially influencing C2orf73 activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
May act as a beta-adrenergic agonist, potentially affecting cAMP-related pathways and C2orf7 | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Could impact Wnt signaling pathway, potentially intersecting with pathways involving C2orf7 | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Might modulate various signaling pathways, potentially impacting C2orf73 activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
May influence a variety of cellular processes, potentially impacting C2orf73 activity. | ||||||